A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 610 participants.
Also called NCT01178073
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 610 participants
- Sponsor
- Registry
-
NCT01178073
-
- Other papers using this trial's data
- Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
- Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
- Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Canada, France, Germany, Greece, Italy, Japan, Netherlands, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01178073. Randomized; quadruple masking; primary purpose treatment. Start 2010-10-01 (registry gives no type); primary completion 2014-07-31 (actual). Results posted on 2015-04-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
- Acronym
- AMBITION
- Condition
- Hypertension, Pulmonary
- Intervention (Drug)
- ambrisentan
- Intervention (Drug)
- tadalafil
- Lead sponsor
- GlaxoSmithKline
- Collaborator
- Gilead Sciences
Record details
- Record id
cardio:ct-nct01178073- Content hash
53e5525d293390b11894665867e954f3c588f30a3ce3876fb6f47f23bf8ba7f3